PCRX (pacira.com) Bozor qiymatining balans qiymatiga nisbati

Pacira Pharmaceuticals (PCRX) kompaniyasining rasmiy ramzlari

Pacira BioSciences (PCRX) grafigidagi narx ko'rsatkichi og'riq qoldiruvchi vositalarni ishlab chiqarish uchun Buyuk Britaniya va AQShdagi o'zining steril ishlab chiqarish korxonalariga tayanadigan biznes dinamikasini aks ettiradi. Biroq, Exparel dori vositasiga nisbatan generik bosim kelgusidagi daromadlar uchun xavf tug'dirmoqda, ular hozirda 2.17 miqdorini tashkil etadi. Shu bilan birga, Pacira BioSciences (PCRX) o'zining ESG strategiyasi doirasida ekologik toza qadoqlarni joriy qilmoqda va zavodning energiya xarajatlarini optimallashtirmoqda.

PCRX Pacira Corp: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 27.10.2026 oraligʻida

Pacira Pharmaceuticals (PCRX) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Pacira BioSciences|PCRX - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Pacira|PCRX - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Pacira BioSciences|PCRX - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com|PCRX - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Pacira BioSciences|PCRX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Pacira|PCRX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Pacira
Kompaniyaning dastlabki tahlili:Pacira BioSciences - PCRX
Pacira original mahsuloti

Ushbu ko'rsatkich tebranishlar bilan bog'liq shovqinlarni filtrlash uchun aksiya narxini kompaniyaning haqiqiy kapitali bilan solishtirish orqali sof aktivlarning bozor qayta baholashini aniqlaydi. Bozor kapitalizatsiyasining bukhgalteriya qiymatiga nisbatini tahlil qilish Pacira BioSciences (PCRX) barqarorligini baholash imkonini beradi, bunda aktivlar premiumi Exparel ning noyob patent himoyasi va opioid bo'lmagan og'riqlarni boshqarish segmentidagi yetakchilik bilan asoslanadi.

Asosiy raqobatchilar

Kapitallashuvning sof aktivlarga nisbati Haleon plc|KVUE (kenvue.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AQST (Aquestive Therapeutics Inc)|SCPH: Bozor qiymatining balans qiymatiga nisbati|TECX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tonix Pharmaceuticals TNXP|SXTC - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati EXOZ (Invizyne Technologies, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti ORMP|Entera Bio Ltd. (ENTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati HYFT (ipatherapeutics.com)|ABVC BioPharma, Inc. (ABVC) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Cumberland Pharmaceuticals Inc CPIX|Quantum BioPharma Limited - Bozor kapitallashuvining balans qiymatiga nisbati|FGEN - Bozor kapitallashuvining balans qiymatiga nisbati|TELO (Telomir Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Rani Therapeutics Holdings, Inc. (RANI) - Kapitallashuvning sof aktivlarga nisbati|SNYR: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi RLYB|Lexaria Bioscience (LEXX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Pulmatrix Corporation (PULM)|Bozor kapitallashuvining balans qiymatiga nisbati PTHL (Pheton Holdings)|APM - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Lyra Therapeutics (LYRA)|IBO - Balans qiymatiga nisbatan bozor qiymati|tnfpharma.com (TNFA) - Bozor kapitallashuvining balans qiymatiga nisbati|cbdMD (YCBD) - Bozor qiymatining balans qiymatiga nisbati|PRFX: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi CYTO|Lipella Pharmaceuticals, Inc. - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti OPTN (OptiNose Inc)|Bozor qiymatining balans qiymatiga nisbati PIRS|Balans qiymatiga nisbatan bozor kapitallashuvi Procaps Group Corp PROC|PTPI: Bozor kapitallashuvining balans qiymatiga nisbati|QLI - Kapitallashuvning sof aktivlarga nisbati|ACELYRIN - Bozor kapitallashuvining balans qiymatiga nisbati|TFF Pharmaceuticals Inc. (TFFP) - Balans qiymatiga nisbatan bozor kapitallashuvi